Found 0 matching trials
Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment
NAAfter detailed history and examination, long luteal protocol will be used f...
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
PHASE3To identify the proportion of patients remaining medically castrated (testo...
Effect of GnRH Agonist in FET
PHASE1To evaluate the impact of single dose GnRH agonist administration as luteal...
Location
Assiut University
Management of Castration-Resistant Prostate Cancer with Oligometastases
PHASE2This adaptive phase II/III randomized trial is designed to demonstrate that...
Status
Active Not Recruiting
Location
BC CANCER Vancouver
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
PHASE2This Investigator-initiated, Treatment of High-Risk Prostate Cancer Guided ...
Location
ZAS Sint-Augustinus
Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.
PHASE2The goal of this study is to evaluate the efficacy and safety of darolutami...
Location
Multiple Locations
Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
NAThe goal of this clinical trial is to learn if Triptorelin test works to ea...
Status
Enrolling By Invitation
Location
Hospital de Niños Dr. Ricardo Gutiérrez
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration
PHASE4The purpose of this study is to compare how subjects feel after receiving i...
Location
Watson Investigational Site
Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
PHASE3The aim of the study is to determine the specificity, sensitivity and diagn...
Location
Hospital de Niños Ricardo Gutierrez, División de Endocrinología
Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success
N/A100 patients aged 21-40 years old, diagnosed as primary or secondary infert...
Location
Multiple Locations